We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Incyte Announces Global License Agreement with Jiangsu Hengrui Medicine for SHR-1210

News   Sep 07, 2015

 
Incyte Announces Global License Agreement with Jiangsu Hengrui Medicine for SHR-1210
 
 
 

RELATED ARTICLES

Hormone Therapy Battles Cognitive Decline

News

A new study has identified benefits of extended estrogen exposure and longer-term hormone therapy in combating cognitive decline

READ MORE

Will a Next-generation Therapy for Diabetes Soon Be Available?

News

In order to improve diabetes therapy, researchers at the University of Geneva (UNIGE), Switzerland, have identified a protein called S100A9 which, under certain conditions, seems to act as a blood sugar and lipid regulator while avoiding the most harmful side effects of insulin.

READ MORE

New Genetic Engineering Tool Opens Floodgates of Microbial Metabolite Applications

News

A team of microbiologists and genomicists led by the Department of Energy Joint Genome Institute (JGI) has invented a genetic engineering tool, called CRAGE, that could not only make studying microbes much easier, but also fill significant gaps in our understanding of how microbes interact with their surroundings and evolve.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE